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Summary. The aim of our study was to document 
whether relationships existed among bone 
morphogenetic proteins (BMPs), peripheral nerve and 
neoplastic lesions of nerve sheath tumors. The mRNA 
transcriptions of BMP-2, 3, 4 and 5 in 10 cases of 
schwannoma, three cases of malignant schwannoma and 
two cases of trigeminal neuralgia were detected using an 
in situ hybridization technique. Our results demonstrated 
that the myelin sheaths of Schwann cell from the 
peripheral neuroectomy of trigeminal neuralgia 
positively expressed mRNA of BMP-2, 3, 4, and 5. The 
most interesting finding was that the nerve fibers of 
trigeminal nerve showed only BMP-2 positive staining. 
All of the neoplastic lesions of nerve sheath showed a 
consistent but variant expression of BMP-2, 3, 4, and 5. 
The expression signals of BMP-2, 3, 5 mRNA in 
malignant schwannoma were relatively lower than in 
benign lesions except for the expression of BMP-4 
mRNA. Our results indicated that selected members of 
BMPs were expressed in the peripheral nerves that might 
contribute to the health maintenance, proliferation, 
regeneration and neoplastic transformation of the 
peripheral nerve system. Furthermore, the effects of 
BMP-2, 3, 4 and 5 on peripheral nervous system during 
neoplastic transformation might be widespread, diverse 
and antagonistic. 
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Introduction 
Bone morphogenetic proteins (BMPs) are a rapidly 
expanding family closely related to the transforming 
growth factor4 (TGF-S) superfamily. BMP irreversibly 
Offprint requests to: Dr. George L. Tipoe, Department of Anatomy, 5th 
Floor, Li Shu Fan Building, 5 Sassoon Road, S.A.R. Hong Kong, P.R. 
China. Fax: (852) 2817-0857. e-mail: tgeorge@hkucc.hku.hk 
induces the differentiation of perivascular mesenchymal- 
type cells into cartilage and bone-forming cells, induces 
ectopic bone formation in vivo and enhances the healing 
of bone defect and bone formation (Sampath et al., 1992; 
Wozney, 1992; Kingsley, 1994). Over the past two 
decades, the knowledge about BMPs including their 
purification, cloning, physicochemical characteristics 
and application have greatly expanded. At least six of 
the BMPs (BMP 2-7) can clearly act as initiators of 
normal bone and cartilage formation and the others may 
also function at the later stages of skeletal growth and 
differentiation (Sampath et al., 1992; Wozney, 1992; 
Kingsley, 1994). Although BMPs have been identified 
by their presence in bone, cartilage and dentin-inductive 
extracts derived from bone, cartilage and tooth, the 
activities of the BMPs are not restricted to hard tissue 
formation. BMP family consists of a large number of 
genetically related molecules, conserved in evolution, 
playing key roles in the development of the kidneys 
(BMP-3, 4 and 7), heart (BMP-2, 4, 6 and 7), lungs 
(BMP-3, 4 and 5 ) ,  small intestines (BMP-3 and 7), 
sperm (BMP-8A) and limb bud (BMP-2, 4, 5 and 7) 
(Vukicevic et al., 1994; Sasai et al., 1995; Kawakami et 
al., 1996; Barlow and Francis-West, 1997; Glinka et al., 
1997; Hemmati-Brivanlou and Melton, 1997; Godin et 
al., 1998; Zhao et al., 1998). Recently, increasing 
evidence suggests that there is a regulatory role of BMPs 
in neurogenesis (Mehler et al., 1997). BMP ligands and 
receptor subunits  are  present throughout neural 
development within discrete regions of the embryonic 
brain and within neural crest-derived migratory zones 
(Fann and Patterson, 1994; Hawley et al., 1995; Varley 
and Maxwell, 1996; Xu et al., 1996; Lo et al., 1997; 
Bengtsson et al., 1998). Previous studies have indicated 
that BMPs regulated neuronal survival and phenotypic 
maturation from more lineage-restricted peripheral and 
central nervous systems progenitor populations (Fann 
and Patterson, 1994; Iwasaki et al., 1996; Mehler et al., 
1997). 
Tumors of neural tissue arise in connection with the 
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sheaths of peripheral nerves, neurogfia and nerve cells. 
Tumors of the nerve sheath are neurilemmoma and 
neurofibroma. Although there is growing evidence to 
indicate the regulatory role and neurotrophic capacity of 
BMPs in neurogenesis, there are no published report 
about the relationships between BMPs and nerve sheath 
tumors and between BMPs and peripheral nerves. Thus, 
the purpose of the present study was to investigate the 
expression of BMPs in the peripheral nerve and nerve 
sheath tumors and to evaluate the possible roles of 
BMPs in the progression and malignant transformation 
of nerve sheath tumors. 
Materials and methods 
Samples 
The samples of nerve sheath tumor were obtained 
from biopsy of surgical patients at the Department of 
Oral Histology and Pathology, Qin Du Stomatological 
Hospital, Fourth Military Medical University, Xi'an, 
People's Republic of China. Lesions were all located in 
the oral maxillofacial region, consisting of ten cases of 
schwannoma (neurilemmoma) and three cases of 
malignant schwannoma. Ages of patients ranged from 25 
to 64 years old. Two control specimens of trigeminal 
nerve fragments were collected by peripheral 
neuroectomy from cases of trigeminal neuralgia. All 
samples were fixed in 10% neutral formalin and 
embedded in paraffin blocks. Five pm thickness sections 
were cut and stained with hematoxylin and eosin for 
histopathological assessment and processed for in situ 
hybridization. 
Preparation of BMPs cDNA probes 
Plasmid pSP65-BMP-2 containing human BMP-2 
cDNA fragment (1.58kb), plasmid PGEX-2T-BMP-3 
containing human BMP-3 cDNA fragment (780bp; 
obtained from Dr. JM Wozney, Genetics Institute, Inc., 
Cambridge, MA, USA), Bluescript KS-BMP4 containing 
human BMP-4 cDNA fragment (l.8kb; obtained from Dr. 
JQ Feng, Division of Endocrinology, University of Texas 
Health Science Center, San Antonio, Texas, USA) and 
pBmp5UT containing human BMP-5 cDNA fragment 
(246bp; obtained from Dr. DM Kingsley, Department of 
Developmental Biology, Stanford University, Stanford, 
California, USA) were labeled with digoxigenin 
according to method of random primed labeling using a 
DIG-Labeling Kit (Roche Diagnostics, Germany). The 
specificity of the BMP cDNA probes was established in 
our previous study (Lu et al., 2000). 
In situ hybridization (ISH) 
I n  situ hybridization was carried out with RNase- 
free materials and solutions. In  situ hybridization kit 
(Roche Diagnostics,  Germany) was used in the 
following procedures according to the manufacturer's 
instructions with some modifications. Briefly, sections 
were dewaxed with xylene, rehydrated in sequential 
ethanols and rinsed in 0.1 % diethylpyrocarbonate 
(DEPC) and phosphate-buffered saline (PBS). Sections 
were treated with 0.2 mol/L HCI solution for 15 rnin and 
0.3% Triton X-100 in PBS for 10 rnin followed by 
digestion with 10 pglml proteinase K (Sigma Chemical 
Co., USA) for 10 min at 37 "C, washed in 0.2% glycine 
in PBS for 10 min and post-fixed in 4% PFA for 30 min. 
Subsequently, sections were dehydrated and dried. 
Hybridization buffers containing 40 ng/ml DIG-labeled 
BMP-2, 3, 4, 5 cDNA probes were applied appropriately 
to each corresponding section. Labeled probes were 
heated for 10 min in a boiling water bath before used. 
After hybridization for 16 h at 42 "C, sections were 
washed sequentially in 2xSSC (standard saline citrate), 
1xSSC (150 mmol/l sodium citrate; 15 mmol/l NaCI, pH 
7.0) at 37 "C, O.5xSSC and buffer I (100 mmol/l Tris- 
HCI; pH 7.5; 150  mmolll  NaCI). Sect ions werc 
incubated with 2% normal goat serum for 30 rnin and 
subsequently incubated with anti-digoxigenin 
Fabtalkaline phosphatase (AP) conjugate for 2 h, then 
immersed in buffer I with shaking, followed by an 
equilibration step in buffer I11 (100 mmol/l TrisHCl; pH 
9.5; 100 mmol/l NaCI; 50 mmol/l MgCI2), and later in 
BCIP (5-bromo-4-chloro-3-indolyphosphate)/NBT (4- 
nitro blue tetrazolium chloride)/levamisole colour 
solution in  the dark for up to 4 h. The colour reaction 
was stopped with 10 mmol/L Tris-HC1 and 1 mmol/L 
EDTA (pH 8.0). Sections were processed in graded 
ethanols,  xylene, and then mounted. For better 
histological observation, some of the sections were 
counterstained in methyl green, washed in 3 changes of 
distilled water and 3 changes of 100% butanol and then 
finally processed in xylene and then mounted. 
Sect ions of osteosarcoma that demonstrated 
consistent expression of BMP-2 mRNA were included in 
each batch of staining to serve as positive control. 
Negative controls were processed similar to the above 
protocol with the omission of the probes in the 
hybridization buffer prior to hybridization procedure or 
after treating sections with RNase (100pglml). 
Results 
No positive staining was seen in the control sections 
without applying probes. Negative staining or obviously 
decreased signal was observed in the control sections 
treated with mRNase prior to hybridization. 
There was a consistent BMP-2, 3, 4 and 5 positive 
staining in the trigeminal nerve. Both the horizontal and 
longitudinal section of the fragments of trigeminal nerve 
showed the expression of BMPs signals. Generally, the 
hybridization signal was highest in BMP-2 than that in 
BMP-3, 4 and 5. The most interesting finding was thal 
the nerve fibers of trigeminal nerve showed only BMP-2 
mRNA positive staining (Fig. lA,B). The myelin sheaths 
of Schwann cell were obviously stained with BMP-2, 3, 
4 and 5, whereas the staining appearance of BMP-3,4, 5 
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presented a reticular form (Figs. 2A,B, 3A,B). The 
various levels of positive signals were also detected in 
the epineurium, perineurium, and endoneurium of 
peripheral nerve. 
The results of in situ hybridization revealed that 
almost all of the lesions showed variant positive staining 
for BMP-2, 3,  4 and 5 .  Microscopically the 
schwannomas showed two distinct cellular patterns 
designated as Antoni type A and Antoni type B. Antoni 
type A tissue consists of cells like fibrocytes together 
with intercellular collagenous tissue. Almost all of the 
tumor cells (fibrocyte-like cells) were BMP-2, 3, 4 and 5 
positively stained, whereas the intensity of BMP-4 and 5 
staining was higher than that of BMP-2 and 3 (Fig. 4). 
The positive s ignals  were obviously seen i n  the 
palisading area, or the region of accumulated tumor cells 
(Figs. 4, SA). There was no detectable staining in the 
matrix of tumor and collagenous fiber. The staining 
intensity was relatively and slightly weak in cells of 
Antoni B tissue when compared with Antoni A tissue. 
Nevertheless, the tumor cells in Antoni B tissue also 
showed BMP-2, 3, 4 and 5 positively staining (Fig. 5B). 
The fibroblasts of schwannoma were negatively stained. 
Almost all of the malignant lesions showed positive 
hybridization signals for BMP-2, 3, 4 and 5 except the 
varied staining intensity of in situ hybridization. When 
comparing the expression of mRNA signals of BMP-2,3 
and 5 except for BMP-4 with benign and malignant 
schwannomas, the latter showed reduced signals (Figs. 
6, 7 and SB). The high level of BMP-4 mRNA signal 
was observed in the neoplastic cells of both malignant 
and benign lesions (Fig. 8A). 
Discussion 
We have previously shown that the expressions of 
BMPs were also present in the neoplasms of bone, tooth, 
cartilage, glandular tissue and other tissues (Jin and 
Yang, 1990a-c; Yang et al., 1993a,b). In particular, we 
found that BMP could influence the progression and 
prognosis of osteosarcoma, chondrosarcoma and benign 
and malignant salivary gland tumors. Experimental 
analysis of BMPs action during neural development is 
still in its infancy. However, rapid and dramatic progress 
have been accomplished in elucidating the role of this 
cxpanding 'TGF-13 subclass in wide diverse cellular 
events during early, intermediate and later stages of 
neurulation, morphogenesis, lineage elaboration and 
phenotypic maturation (Liem et al., 1995; Varley and 
Maxwell, 1996; Hemmati-Brivanlou and Melton, 1997; 
Mehler et al., 1997; Bengtsson et al., 1998). However, it 
still remains unknown about the expressions and the 
roles of BMPs in  the postnatal nerve system, particularly 
in the peripheral nervous system (PNS). Thus, the aim of 
our present study was to investigate the patterns of 
expression and distribution of BMPs in the postnatal and 
neoplasms of the PNS, and to determine the possible 
roles of BMPs in the generation and progression of the 
neoplasms of PNS. Our results showed that there was a 
consistent BMP-2, 3, 4 and 5 positive hybridization 
signals in the myelin sheaths of Schwann cell of the 
trigeminal nerve. Generally, the positive signal was 
highest in BMP-2 staining than in BMP-3, 4, and 5.  The 
most interesting finding was that the nerve fibers of 
trigeminal nerve expressed BMP-2 mRNA only. 
The specific cellular binding proteins of BMP-2 on 
neuronal cells seems particularly interesting as several of 
the TGF-B superfamily members have recently been 
shown to possess neurotrophic activity (Iwasaki et al., 
1996; Mehler et al., 1997). BMP-2 induces the neuronal 
differentiation of rat pheochromocytoma PC12 cells with 
concomitant expression of three neurofilament proteins 
(Iwasaki et al., 1996) and in concert with tumor necrosis 
factor (TNF), i t  plays an essential role in regulating the 
regeneration of peripheral nerves through an indirect 
mechanism by which it stimulates nerve growth factor 
(NGF) production in fibroblasts (Hattorl et al., 1996). 
Mabie et al. (1997) found that the BMPs act as potent 
inductive factors in postnatal glial lineage commitment 
that initiate a stable program of astroglial differentiation. 
Our findings further demonstrated that BMP-2, 3, 4 and 
5 ,  particularly BMP-2 and 4 might play an important 
role in the healthy maintenance and pathological 
changes of peripheral nerve by means of autocrine or 
paracrine pathway. We propose that the selected 
members of BMP family might be able to influence the 
status of peripheral nerves through Schwann cells (SCs). 
SCs  of neural crest-derived cells,  have been 
demonstrated to be active participants in the recovery 
from peripheral nerve damage and promoting CNS 
axonal regeneration (Levi et al., 1997). A number of 
studies have demonstrated that the addition of SCs 
within channels or grafts dramatically improves the 
regeneration of PNS neurites.  S C s  produce both 
neurotrophic factors such as NGF, brain derived 
neurotrophic factor and ciliary neurotrophic factor, and 
the extracellular matrix molecules such as laminin and 
collagen. Our present results further proved that SCs 
could synthesize and secrete BMP-2, 3, 4 and 5, that 
might have selective effects on the nerve fibers. Our 
study also showed the sole expression of BMP-2 in the 
nerve fiber of trigeminal nerve. Although it is still not 
clear on how the detected transcription mRNA of BMP- 
2 was synthesized and transported, it seemed that there 
was an interaction between nerve fiber and SCs. BMP-2 
appearing to be another neurotrophic factor such as NGF 
or basic fibroblast growth factor, which might play a 
critical role in the growth and proliferation of both nerve 
fiber and SCs. 
Benign schwannoma is a rather common tumor 
derived from SCs,  which form the nerve sheath. 
Malignant nerve sheath tumor usually arises as a result 
of either de novo or malignant change in pre-existing 
neurofibromas, particularly in cases of neurofibro- 
matosis. Structurally, malignant nerve sheath tumors 
consist of fusiform cells and fibers, closely resembling 
fibrosarcoma. Occasionally, a palisading arrangement 
that represent the typical morphological appearance of 
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Schwannoma is present and it aids in the diagnosis of the 
malignant lesion (Casadei et al., 1995; Kindblom et al., 
1995; Chrysomali et al., 1997; Hasegawa et al., 1997). 
Relatively little is known about the molecular genetic 
alterations that underlie their formation (Halling et al., 
1996). Up to date, there is no published report on the 
relationship between BMPs and benign or  malignant 
nerve sheath tumors. Our results revealed that almost all 
of the lesions showed variant transcriptional mRNA 
signals of BMP-2, 3, 4 and 5 in both tumor cells in 
Antoni type A or B tissues. The positive signals were 
observed in the palisading area or  in the area of the 
accumulated tumor cells. Although all of the malignant 
l e s ions  s h o w e d  pos i t ive  s t a i n i n g ,  the  ma l ignan t  
schwannoma showed reduced transcriptional mRNA 
signals of BMP-2, 3 and 5 when compared with the 
benign lesions, except for the expression of BMP-4. It 
was not yet clear why the expression signals of BMP-2, 
3, 5 were decreased in the malignant than in the benign 
lesions. Previous reports have indicated that BMPs  
might exert selective effects and might have opposite 
influences on the proliferation,  differentiat ion and 
morphogenesis of neural cells (Fann et al., 1994; Hawley 
et al., 1995; Xu et al., 1996, 1997; Hemmati-Brivanlou 
and Melton, 1997; Lo et al., 1997; Mehler et al., 1997). 
BMP-2 and BMP-6 could induce mRNAs for distinct 
sets  of neuropeptides and neurotransmitter synthetic 
enzymes in rat neural crest-derived sympathetic neurons 
(Fann et al., 1994). BMP-2 and BMP-4 were able to 
induce expression of MASH1 and to promote autonomic 
neuronal differentiation in neural crest stem cells (Lo et 
al., 1997). Several reports indicates that BMP-4 might be 
a neural inhibitor (Hawley et al., 1995; Sasai et al., 1995; 
Hemmati-Brivanlou and Melton, 1997; Xu et al., 1997). 
Whereas Xu et al. (1996, 1997) have shown that BMP-4 
was a ventralizing factor in Xenopus body patterning. 
Several studies have suggested that other types of BMP 
could fulfil1 the same neural inhibitory activity of those 
dominant negative BMP ligands that have a pleiotropic 
inhibitory effect on all BMPs (Hawley et al., 1995; 
Hemmati-Brivanlou and Melton, 1997). Some studies 
sugges ted  that  the  ac t ion  of  B M P  f a c t o r s  in the  
developing nervous system is dependent on the species, 
part icular cell  type and developmental  s tage  being 
examined (Fann et al., 1994; Varley et al., 1996). Our 
results indicated that changes in the expression of BMP- 
2 ,  3, 4 and  5 occur red  d u r i n g  the  neop las t i c  and  
malignant transformation of Schwann cells  and the 
expressions of BMP-2, 3 and 5 were  relatively and 
slightly reduced. The effects of BMP-2, 3, 4 and 5 on 
PNS might be widespread, diverse and antagonistic. 
Although the expression of BMPs in both benign 
and malignant nerve sheath tumors was evidently shown, 
the roles of BMPs during the neoplastic transformation 
of SCs and progression of nerve sheath tumors were not 
clearly understood. We cannot exclude the possibility 
that there might be mutant types of BMPs gene during 
neoplastic or  malignant transformation of peripheral 
nerve.  Nevertheless,  o u r  results  indicated that the  
positive hybridization signals of BMPs  might be an 
indicator in the differentiation of malignant schwannoma 
and fibrosarcoma. It is accepted that foci of cartilaginous 
a n d  o s s e o u s  modu la t ion  cou ld  be  found  in s o m e  
malignant schwannomas. Although we did not observe 
the formation of tumorous  cart i lage or  bone in our 
collected lesions, our present results indicated that BMPs 
secreted by tumorous cells of benign and malignant 
schwannomas might contribute in the bone or cartilage- 
induction of some malignant schwannomas. 
In conclusion, we demonstrated that the expression 
of BMP-2, 3, 4 and 5 might be a common event in the 
peripheral nerve system. Almost all of the tumor cells of 
the benign and malignant nerve sheath tumors showed 
variant expressions of BMP-2, 3, 4 and 5. The effects of 
BMP-2, 3, 4 and 5 on PNS might be widespread, diverse 
and antagonistic. Our results indicated that BMP-2, 3, 4 
and 5 ,  part icularly BMP-2  and BMP-4  might play 
critical roles in the normal and pathological changes of 
PNS. BMP-2, 3, 4 and 5 were involved in the neoplastic 
transformation of the Schwann cells of PNS and they 
might  con t r ibu te  to the  neop las t i c  and  mal ignant  
transformation of peripheral nerve cells. Further studies 
are needed to clarify the effect of each individual BMPs 
and SMADs in the growth, regeneration or degeneration 
b 
Fig. l. Trigeminal nerve showing positive hybridization signals of BMP-2 in the myelin sheath and nerve fibers. X 100 
Fig. 2. Longitudinal (A) and horizontal (B) sections of trigeminal nerve showing the positive hybridization signals of BMP-3 mRNA in the myelin sheath 
of Schwann cells, X l 00  
Fig. 3. The longitudinal section of a trigeminal nerve. BMP-4 (A) and BMP-5 (B) are obviously expressed in the myelin sheath of nerve. X 100 
Fig. 4. The tumor cells of schwannoma showing overexpression of BMP-4 mRNA. X 100 
Fig. 5. A. Palisading area of the schwannoma is strongly positive for BMP-2 mRNA. B. Schwannoma cells in Antoni B area showing positive for BMP-5 
mRNA. X 100 
Fig. 6. Tumor cells of malignant schwannoma showing BMP-2 positively stained. X 200 
Fig. 7. Tumor cells of malignant schwannoma showing BMP-4 positively stained. X 200 
Flg. 8. A. The BMP-3 positive signal is shown in the cytoplasm of tumor cells of malignant schwannoma (no counter-stain). B. While BMP-5 positive 
signal is shown in some of the tumor cells of malignant schwannoma. X 200 

BMPs expression in trigeminal nerve and nerve sheath tumors 
of PNS and the relationship between each individual 
BMPs and clinico-pathological features of benign and 
malignant schwannornas. 
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